PIONEERING PROTEIN MEDICINAL CHEMISTRY
Dead / Cancelled — Cancelled — Section 8 (as of 25 Nov 2016)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78327222
- Registration number
- 3779512
- Mark type
- Stylized text
- Filed
- 13 Nov 2003
- Published for opposition
- 28 Mar 2006
- Registered
- 20 Apr 2010
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services
Owner
- Ambrx, Inc., La Jolla, CA, US
- Ambrx, Inc., La Jolla, CA, US
- Ambrx, Inc., San Diego, CA, US
Prosecution history
- 25 Nov 2016 — CANCELLED SEC. 8 (6-YR)
- 17 May 2016 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 May 2016 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Apr 2015 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Apr 2010 — REGISTERED-PRINCIPAL REGISTER
- 16 Mar 2010 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
- 15 Mar 2010 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 15 Mar 2010 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Feb 2010 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Feb 2010 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Feb 2010 — ASSIGNED TO LIE
- 01 Feb 2010 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Jul 2009 — NON-FINAL ACTION MAILED
- 30 Jul 2009 — SU - NON-FINAL ACTION - WRITTEN
- 13 Jul 2009 — STATEMENT OF USE PROCESSING COMPLETE